A randomised, two-way crossover study to compare the pharmacokinetics of testosterone following application of a Testosterone Metered Dose (MD) lotion or AndroGel in men with low serum testosterone

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000517673

Enrollment

Registered

2005-09-26

Start date

2004-02-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Testosterone Metered Dose (MD) lotion and AndroGel, single doses (i.e. for one day each).

Study design

Allocation

Randomised controlled trial

Intervention model

Crossover

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

Male

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Hypoandrogenic males, who were otherwise healthy.

Exclusion criteria

No exclusion criteria

Outcome results